Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 51.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 52.50
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

23 Mar 2015 07:00

RNS Number : 0982I
Frenkel Topping Group PLC
23 March 2015
 

23 March 2015

 

Frenkel Topping Group plc

("Frenkel Topping" or "the Company")

 

Final Results

 

Frenkel Topping (AIM: FEN), a leading provider of specialist independent financial advice on the investment of personal injury damages and clinical negligence awards, announces audited final results for the year ended 31 December 2014, which has been another strong year with continued growth in revenues, pre-tax profits and funds under management.

 

Financial Highlights

· Revenue up 3.3% to £5.69m (2013: £5.51m)

§ Recurring revenue of £4.20m (2013: £3.86m)

· Gross profit up 9.9% to £3.90m (2013: £3.55m)

· Operating profit (before share based payments) up 21.7% to £1.75m (2013: £1.44m)

· Pre-tax profit up 12.2% to £1.57m (2013: £1.39m)

· Basic EPS up 24.7% to 2.27p (2013: 1.82p)

· Assets under management up 10.9% to £619m (as at 31 December 2013: £558m)

· Net cash of £1.70m (as at 31 December 2013: £1.52m)

· Total dividends (paid and proposed) up 22.4% to 0.71p per share (2013: 0.58p)

 

Operational Highlights

· Sixth consecutive year of 99% client retention for investment management services

· Renewed focus on expert witness work to establish good relationships pre-settlement

· Revenue generating Fee Earning Consultants up from nine to 14

· Expansion of geographical footprint in England and Wales

· Investing in the network of Fee Earning Consultants across England and Wales which is expected to accelerate growth from 2016 onwards

 

David Southworth, Chairman of Frenkel Topping, commented: "The Company is in a very strong position as a leader in our market, but also financially, to continue to grow the business and to increase funds under management substantially. We are investing in increasing our network of Fee Earning Consultants across England and Wales which we expect will have a positive impact on growth rates from 2016 onwards, in terms of both profits and funds under management. The new financial year has started well and we are confident that we can deliver accelerated growth in the years to come."

 

 

For further information:

 

Frenkel Topping Group plc

www.frenkeltopping.co.uk

Richard Fraser, Managing Director

Tel: 0161 886 8000

Julie Dean, Finance Director

 

 

 

Shore Capital

Tel: 020 7408 4090

Pascal Keane / Patrick Castle

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or frenkeltopping@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Nick Rome

Mob: 07748 325 236

 

 

About Frenkel Topping: www.frenkeltopping.co.uk

 

Frenkel Topping provides specialist independent financial advice on the investment of personal injury damages and clinical negligence awards. Frenkel Topping offers a complete service for all personal injury claims handlers, lawyers and individual clients, dealing with awards from a few thousand pounds to multi-million pound cases. The Company is a well recognised provider of expert witness reports in these cases and is then able to offer financial advice following settlement of the claim.

 

The Company's expertise includes asset protection, bespoke investment portfolios, analysis of periodical payments, Court of Protection portfolios and provision and setting up of trustee and receivership bank accounts.

 

Chairman's Report

 

2014 has been another successful year for Frenkel Topping, during which we have seen continued growth in revenues, pre-tax profits and funds under management. We are particularly pleased with the improvement in margins during the period and the strong cash generation of the business, which provides us with the confidence to increase total dividend payments in the year by over 20%.

 

Whilst this is a solid set of results, and it is pleasing to announce growth in line with market expectations, we know that the business has the potential to deliver much higher rates of growth. We believe there is an opportunity to invest now in the business which we expect will deliver accelerated growth from 2016 onwards, and we remain confident that we can extend our leading position within the personal injury and clinical negligence market. During the period of growth we expect to continue to deliver strong cash generation which will allow for a progressive dividend policy.

 

Results

 

Revenue for the year increased by 3.3% to £5.69m (2013: £5.51m), of which £4.20m was contributed from recurring revenues and these now account for 74% of total revenues (2013: 70%). We are pleased to report that for the sixth consecutive year we have maintained our 99% client retention rate for the period.

 

Gross profit was up by nearly 10% to £3.90m (2013: £3.55m) whilst operating profit before share based payments rose by 21.7% to £1.75m (2013: £1.43m). This resulted in margin improvement across the Company, with gross margins now at 68.4% (2013: 64.4%), and operating margins up to 30.7% (2013: 26.1%).

 

Reported profit before taxation increased by 12.2% to £1.57m (2013: £1.39m), after reflecting an increase in share based payments compared to the previous year.

 

The Company generated £1.41m of cash from operating activities during the year (2013: £1.72m) and finished the year with a net cash balance of £1.70m (2013: £1.52m), even after the purchase, by the employee benefit trust, of the Company's own shares during the year totaling £407,072 and the payment of £458,731 to shareholders in dividends, including the Company's first ever interim dividend.

 

Assets in the Investment Management Service business increased by 10.9% to £619m (as at 31 Dec 2013: £558m).

 

Dividend

 

We are delighted to continue to advance our progressive dividend policy and the Board has recommended a final dividend of 0.54 pence. Combined with our maiden interim dividend the proposed dividend will give a total payment for the year of 0.71 pence, a 22.4% uplift to last year (2013: 0.58 pence), and a recognition of the continued growth of the business.

 

Subject to shareholder approval at the Company Annual General Meeting on 19 May 2015, the final dividend will be paid on 12 June 2015 to shareholders on the register at the close of business on 29 May 2015. The ex-dividend date is 28 May 2015. 

 

Operational Review

 

The long term strategy of the Company is to grow the assets in the Investment Management Service business and to provide an excellent service to clients both pre- and post-settlement and to maintain that relationship following its initial advice. During the period we exceeded £600m of funds under management and we are very proud to record our sixth consecutive year of retaining 99% of the clients using our investment management services.

 

The main driver for new business, and subsequent contributor to our funds under management, is our provision of expert witness reports for clients who are in the process of litigation as a result of a personal injury or clinical negligence claim. The focus during 2014 has been to continue to market Frenkel Topping's expert witness services to clients and litigation professionals, building up strong relationships pre-settlement, which we hope will in turn lead to the provision of personal injury trust work or investment advice.

 

Whilst we have seen good success in this endeavour to date, we know that there is a huge opportunity to grow this business and to extend our network of Fee Earning Consultants across England and Wales. At the beginning of the year we employed nine staff in this important revenue generating role and by the end of the year we extended this to 14. In doing so we have been able to add high quality, qualified staff with expertise in chartered financial planning, SOLLA (Society of Later Life Advisers) and STEP (Society of Trust and Estate Practitioners). It is our intention to continue to invest in this area of the business through 2015 and to ensure that Frenkel Topping has strong well qualified representation across key regional litigation communities, namely in the North West, the West Midlands, London, Bristol and South Wales.

 

During the year we continued to invest in supporting our network of litigation professionals and extend the Frenkel Topping brand as a specialised provider of financial advice in our area. Last year we hosted and supported a number of events aimed at clinical negligence solicitors, professional deputies, barristers, Court of Protection specialists, private client teams and case managers. Our annual Deputy Day Conference in May 2014 was very well attended, and in November 2014 we held our first Deputy Day in Cardiff. We are organising and supporting a number of events in 2015 details of which can be seen here: http://www.frenkeltopping.co.uk/professionals/events/

 

As well as these wider events our business development consultants regularly hold surgeries for law firms and other professionals within the personal injury and clinical negligence community to provide them with the latest update on our "best of breed" investment services and advice on current or forth coming issues. These can range from the impact changes to the Office of the Public Guardian will have on Court of Protection appointed deputies, to the implications of the US's new FATCA (Foreign Account Tax Compliance Act) or the challenges that arise from the Care Act. In September 2014, we collaborated with a leading claimant barristers' chambers in London during their Annual Personal Injury Conference held at the Law Society in Chancery Lane and we were delighted to be invited to present at the Society of Clinical Injury Lawyers' annual conference in November last year.

 

2014 marked the 25-year anniversary of the landmark case of Kelly vs. Dawes which resulted in Britain's first ever structured settlement, known as a Periodical Payment Order ("PPO") in which Frenkel Topping played an integral part. This was a pivotal development in personal injury law, providing a guaranteed, tax-free income for the lifetime of a claimant and was a precursor to the current periodical payment regime. The lasting legacy of this case has had a huge impact on many other severely disabled and injured individuals and their families and we are incredibly proud to have had such a key role.

 

During the year we were very pleased to receive external recognition of the team's hard work by being shortlisted for a number of awards. Frenkel Topping was shortlisted in the 'Supporting the Profession' category of the Modern Law awards 2014 and in the 'Associated Industries' category of the Eclipse Proclaim Personal Injury Awards 2014. In addition, our Finance Director, Julie Dean was shortlisted for the Finance Director of the Year Award at the Grant Thornton Quoted Company Awards. This recognition is a reflection of our growing profile in the industry. 

 

Outlook

 

Whilst we are pleased to have further increased our funds under management, we are well aware of the huge opportunity we have to grow the business at an accelerated rate. We know that we can do this by extending our geographical reach across England and Wales and through investing in our core base of revenue generating Consultants.

 

In 2015 we expect to increase the number of Fee Earning Consultants from 14 to 16, and to develop a stronger network around key regional cities; not only in Manchester, where we already have a very strong base, but also in and around Birmingham, London, Bristol and Cardiff. In these areas we will further extend our support for litigation professionals through the provision of our expert witness services and by offering their clients our premium investment solutions and advice.

 

In the wake of the changes that are taking place across the legal sector we increasingly find that the decision of who to instruct for expert witness work and to ultimately provide investment advice is moving away from individual litigators towards the senior partners, managing directors or chief operating officers of law firms. In addition we have seen the emergence of a number of sizeable but very specialist personal injury and clinical negligence law firms. Given our strong reputation and long track record in this field, as well as the added transparency and good corporate governance required of us as a public company, we are in an excellent position to take advantage of this shift.

 

The Company is in a very strong position, not only as a leader in a niche market, but also from a financial point of view, to continue to grow the business and to increase funds under management substantially. Whilst investment in this growth will result in an increase in our cost base this year, we are confident that we will see this investment bring about a step change in performance from 2016 onwards and will have a positive impact on growth rates for profits and funds under management. The new financial year has already started well and we are confident that we can deliver this accelerated growth.

 

 

David Southworth

Chairman

 

 

GROUP INCOME STATEMENT

For the year ended 31 December 2014

 

2014

2013

Notes

£

£

REVENUE

3

5,693,266

5,507,736

Direct staff costs

(1,796,734)

(1,959,948)

GROSS PROFIT

3,896,532

3,547,788

ADMINISTRATIVE EXPENSES

 

Share based compensation

(174,142)

(33,705)

Other

(2,146,721)

(2,111,085)

TOTAL ADMINISTRATIVE EXPENSES

(2,320,863)

(2,144,790)

 

Profit from operations before share based compensation

 

1,749,811

 

1,436,703

- share based compensation

(174,142)

(33,705)

profit from operations

1,575,669

1,402,998

Finance costs

(6,972)

(10,927)

profit BEFORE TAX

1,568,697

1,392,071

Income tax expense

4

(203,646)

(291,992)

profit and total comprehensive INCOME for the year

1,365,051

1,100,079

profit and total comprehensive INCOME ATTRIBUTABLE TO:

Owners of the parent undertaking

1,365,051

1,087,925

Non-controlling interest

-

12,154

1,365,051

1,100,079

Earnings per ordinary share - basic (pence)

5

2.27p

1.82p

Earnings per ordinary share - diluted (pence)

5

2.19p

1.76p

 

GROUP STATEMENT OF FINANCIAL POSITION

As at 31 December 2014

 

2014

2013

Notes

£

£

assets

NON CURRENT ASSETS

Goodwill

Property, plant and equipment

 

 

5,095,287

12,990

5,095,287

37,076

Deferred taxation

202,627

61,610

5,310,904

5,193,973

CURRENT ASSETS

Accrued income

Trade receivables

Other receivables

 

933,428

882,249

158,634

1,058,054

983,390

143,263

Cash and cash equivalents

1,959,556

1,896,932

3,933,867

4,081,639

total assets

9,244,771

9,275,612

equity and liabilities

equity

Share capital

Merger reserve

Other reserve

Own shares reserve

Retained earnings

 

 

 

 

319,186

929,577

(341,174)

(774,197)

8,082,486

 

316,161

929,577

(341,174)

(367,125)

6,999,524

 

equity attributable to owners of parent undertaking

8,215,878

7,536,963

Non-controlling interests

490

-

TOTAL EQUITY

8,216,368

7,536,963

 

NON CURRENT LIABILITIES

Obligations under finance lease

 

 

 

 

-

 

15,211

-

15,211

CURRENT LIABILITIES

Bank overdrafts

Current taxation

Trade and other payables

Provisions

 

 

 

 

 

255,841

140,252

632,310

-

372,381

141,399

1,209,658

-

 

1,028,403

1,723,438

TOTAL LIABILITIES

1,028,403

1,738,649

TOTAL EQUITY AND LIABILITIES

9,244,771

9,275,612

 

GROUP STATEMENT OF CHANGES IN EQUITY

For the year ended 31 December 2014

 

Share Capital

Merger reserve

Other

Reserve

Own share

Reserve

Retained Earnings

 

Total

controlling

interest

Non controlling interests

Total

£

£

£

£

£

£

£

£

Balance 1 January 2013

 

290,447

 

-

 

-

 

(270,656)

 

6,058,406

 

6,078,197

 

597,375

 

6,675,572

New shares issued

4,587

-

-

-

-

4,587

-

4,587

Share based

compensation

 

-

 

-

 

-

 

-

 

33,705

 

33,705

 

-

 

33,705

Purchase non

controlling Interest

 

21,126

 

929,577

 

(341,174)

 

-

 

-

 

609,529

 

(609,529)

 

-

Own Shares

purchased

 

-

 

-

 

-

 

(96,469)

 

-

 

(96,469)

 

-

 

(96,469)

Dividend Paid

-

-

-

-

(180,512)

(180,512)

-

(180,512)

Total transactions

with owners

recognised in equity

 

 

316,161

 

 

929,577

 

 

(341,174)

 

 

(367,125)

 

 

5,911,599

 

 

6,449,058

 

 

(12,154)

 

 

6,436,884

Profit and total

Comprehensive

income for

the period

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,087,925

 

 

 

1,087,925

 

 

 

12,154

 

 

 

1,100,079

Balance 1

January 2014

 

316,161

 

929,577

 

(341,174)

 

(367,125)

 

6,999,524

 

7,536,963

 

-

 

7,536,963

New shares issued

3,025

-

-

-

-

3,025

-

3,025

Share based

compensation

 

-

 

-

 

-

 

-

 

174,142

 

174,142

 

-

 

174,142

Subsidiary share award adjustment

-

-

-

-

2,500

2,500

-

2,500

Own Shares

purchased

 

-

 

-

 

-

 

(407,072)

 

-

 

(407,072)

 

-

 

(407,072)

Dividend paid

Non controlling interest purchased in year

-

-

-

-

-

-

-

-

 (458,731)

-

 (458,731)

-

-

490

 (458,731)

490

Total transactions

with owners

recognised in equity

319,186

929,577 

(341,174)

(774,197)

6,717,435

6,850,827 

490

6,851,317

Profit and total

Comprehensive

income for the

period

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,365,051

 

 

 

1,365,051

 

 

-

 

 

 

1,365,051

Balance 31

December 2014

 

319,186

 

929,577

 

(341,174)

 

(774,197)

 

8,082,486

 

8,215,878

 

490

 

8,216,368

 

· The share capital represents the number of shares issued at nominal price. The merger reserve represents the cost of the shares issued to purchase the non-controlling interest at market value at the date of the acquisition.

 

· The other reserve represents the excess paid for the non-controlling interest over the book value at the date of the acquisition.

 

· The own shares reserve represents the cost of 3,218,016 (2013: 2,124,823) shares held by an employee benefit trust. The open market value of the shares held at 31 December 2014 was £1,303,296 (2013: £658,695).

 

· Retained earnings represents the profit generated by the Group since trading commenced, together with dividends paid, share premium cancelled and share based payment and credits.

 

· The non-controlling interests represents the value of the part of the subsidiary owned outside the Group.

 

· The Group has conformed with all capital requirements as imposed by the FCA.

 

 

GROUP CASH FLOW STATEMENT

For the year ended 31 December 2014

 

Year ended

Year ended

31 December 2014

31 December 2013

£

£

 

Profit before tax

1,568,697

1,392,071

 

Adjustments to reconcile profit for the year to cash (used in)/generated from operating activities:

Finance cost

 

 

 

6,972

 

 

 

10,927

Share based compensation

174,142

33,705

Depreciation and amortisation

13,936

14,286

Subsidiary share award

2,500

-

(Increase) in accrued income, trade and other receivables

210,396

(320,536)

Increase/(decrease) in trade and other payables

(570,411)

586,909

Cash generated from operations

1,406,232

1,717,362

Income tax paid

(346,424)

(256,026)

Cash generated from operating activities

1,059,808

1,461,336

Investment activities

Acquisition of property, plant and equipment

(5,948)

(4,130)

Cash used in investment activities

(5,948)

(4,130)

Financing activities

Shares issued

3,025

4,587

Dividend paid

(458,731)

(180,512)

Interest on loans and borrowings

Finance lease repayments

(3,883)

(8,035)

(4,501)

(8,035)

Own share purchase

(407,072)

(96,469)

Cash used in financing

(874,696)

(284,930)

 

Increase in cash and cash equivalents

 

179,164

 

1,172,276

 

Opening cash and cash equivalents

 

1,524,551

 

352,275

Closing cash and cash equivalents

1,703,715

1,524,551

 

Reconciliation of cash and cash equivalents

 

 

Cash at bank and in hand

1,959,556

1,896,932

Overdraft

(255,841)

(372,381)

Closing cash and cash equivalents

1,703,715

1,524,551

 

Cash and cash equivalents are held at National Westminster Bank Plc.

 

NOTES TO THE FINANCIAL STATEMENTS

For the year ended 31 December 2014

 

1.  General information

 

The preliminary financial information does not constitute full accounts within the meaning of section 434 of the Companies Act 2006 but is derived from accounts for the years ended 31 December 2014 and 31 December 2013. The figures for the year ended 31 December 2014 are audited. The preliminary announcement is prepared on the same basis as set out in the statutory accounts for the year ended 31 December 2014. Those accounts, upon which the auditors issued an unqualified opinion, did not include a reference to any matters to which the auditors drew attention by way of emphasis, without qualifying their report, and made no statement under section 498(2) or (3) of the Companies Act 2006, will be delivered to the Registrar of Companies following the Annual General Meeting.

 

Statutory accounts for the year ended 31 December 2013 have been filed with the Registrar of Companies. The auditors' report on those accounts was unqualified, did not include a reference to any matters to which the auditors drew attention by way of emphasis, without qualifying their report, and did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

 

While the financial information included in this preliminary announcement has been prepared in accordance with the recognition and measurement criteria of International Financial Reporting Standards (IFRS), as adopted by the European Union (EU), this announcement does not in itself contain sufficient information to comply with IFRSs. 

 

Frenkel Topping Group Plc is incorporated and domiciled in the United Kingdom.

 

2. significant accounting policies

 

GOING CONCERN

The financial statements are prepared on a going concern basis, which assumes the Group will continue in operational existence for the foreseeable future. The Group's ability to meet its future working capital requirements and therefore continue as a going concern is dependent upon it being able to generate significant revenues and free cash flow. The Directors have prepared projections which they consider to be prudent and demonstrate that the business can operate within its existing cash resources, and have identified a series of realistically achievable actions that they are committed to taking to mitigate the rate of cash outflow should revenues not be secured as predicted.

 

3. revenue and SEGMENTAL REPORTING

 

All of the Group's revenue arises from activities within the UK. Management considers there to be only one operating segment within the business based on the way the business is organised and the way results are reported internally.

 

4. TAxation

 

2014

2013

 

£

£

Analysis of charge in year

 

 

Current Tax

 

 

 

UK corporation tax

330,572

308,911

 

Adjustments in respect of previous periods

14,091

(12,159)

 

 

 

 

 

Total current tax charge

344,663

296,752

 

 

 

 

 

Deferred tax

 

 

 

Temporary differences, origination and reversal

(141,017)

(4,760)

 

 

 

 

 

Total deferred tax charge

(141,017)

(4,760)

 

 

 

 

 

Tax on profit on ordinary activities

203,646

291,992

 

 

 

 

 

Factors affecting tax charge for year

 

The tax assessed for the period is higher than the main rate of corporation tax in the UK 21.5% (2013: 24%). The differences are explained below:

 

 

2014

2013

 

£

£

Profit before taxation

1,568,696

1,392,071

 

 

 

Profit multiplied by main rate of corporation tax

in the UK of 21.5% (2013: 24%)

337,270

334,097

Effects of:

Expenses not deductible

9,628

14,722

Exercise of share options

(50,173)

(52,757)

Share based payments

(103,576)

8,089

Other charges/ (deductions) in period

10,497

(12,159)

 

 

 

 

 

 

Total tax expense for year

203,646

291,992

 

 

 

 

 

 

 

5. EARNINGS PER SHARE

The calculation of the basic and diluted earnings per share is based on the following data:

 

2014

2013

 

£

£

Earnings

 

 

Earnings for the purposes of basic earnings per share (net profit for the year attributable to equity holders of the parent)

1,365,051

1,087,925

Earnings for the purposes of diluted earnings per share

1,365,051

1,087,925

 

 

 

Number of shares

 

 

Weighted average number of ordinary shares for the purposes of basic earnings per share

Weighted average shares in issue

63,281,887

61,938,332

Less: own shares held

 

(3,128,016)

 

 

(2,124,823)

 

 

Effect of dilutive potential ordinary shares:

60,153,871

 

59,813,509

 

- Share options

2,294,873

2,114,225

 

 

 

Weighted average number of ordinary shares for the purposes of diluted earnings per share

62,373,744

61,927,761

 

 

 

 

 

 

 

 

 

6. Basis of the preliminary announcement

 

The board of directors of Frenkel Topping Group Plc approved the Preliminary Results on 20 March 2015.

 

The statutory accounts for the year ended 31 December 2014 will be delivered to the Registrar of Companies following the Annual General Meeting. The statutory accounts will be posted to shareholders on 30 March 2015. Further copies will be available to the public, free of charge, at the Company's registered office, 4th Floor, Statham House, Talbot Road, Old Trafford, Manchester, M32 0FP and the Company's website at www.frenkeltopping.co.uk

 

7. ANNUAL GENERAL MEETING

 

The Annual General Meeting will be held on 19 May 2015 at 10am at Addleshaw Goddard LLP, 100 Barbirolli Square, Manchester, M2 3AB.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PKKDNABKDPNB
Date   Source Headline
1st May 202410:25 amRNSHolding(s) in Company
23rd Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
22nd Apr 20247:01 amRNSAcquisition
22nd Apr 20247:00 amRNSFinal Results
12th Mar 20247:00 amRNSNotice of Results
20th Feb 20247:00 amRNSDirectorate Change
24th Jan 20247:00 amRNSTrading Update & New Debt Facility
22nd Dec 20238:00 amRNSHolding(s) in Company
13th Nov 20237:00 amRNSPartnership Programme Grows with New Joint Venture
8th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20238:30 amRNSHolding(s) in Company
3rd Oct 20237:00 amRNSThe Shares and AJ Bell Media investor event
3rd Oct 20237:00 amRNSAppointment of Strategy & Implementation Director
29th Sep 20237:00 amRNSInterim Results
31st Aug 202310:08 amRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSDirector Share Purchase
22nd Aug 20237:00 amRNSTrading Update
31st Jul 20237:00 amRNSFEN Announces Joint Venture with Lime Solicitors
21st Jul 20233:20 pmRNSIssue of consideration shares
6th Jul 20237:00 amRNSFEN announces New Major Trauma Centre
20th Jun 20237:00 amRNSDirector/PDMR Shareholding
14th Jun 202312:20 pmRNSResult of AGM
5th Jun 20237:00 amRNSFEN announces New Major Trauma Centre
15th May 20234:15 pmRNSAnnual Report Posting, Notice of AGM & Dividend
24th Apr 20237:00 amRNSFinal Results
22nd Mar 20234:00 pmRNSHolding(s) in Company
15th Mar 202311:47 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSInvestor Presentation
13th Feb 20237:00 amRNSFrenkel Topping Partnership Programme Grows
7th Feb 20237:00 amRNSTrading Update and Notice of Results
10th Nov 20222:50 pmRNSInterim Dividend Timetable
3rd Nov 20227:00 amRNSFEN to present at AJ Bell investor webinar
24th Oct 20222:30 pmRNSDirector/PDMR Shareholding and Holdings in Company
24th Oct 202212:15 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSCompletion of Two Acquisitions
31st Aug 20222:15 pmRNSNotice of Results
3rd Aug 202210:17 amRNSHolding(s) in Company
3rd Aug 202210:15 amRNSHolding(s) in Company
29th Jul 202212:15 pmRNSResult of General Meeting
25th Jul 20227:00 amRNSFEN Announces Joint Venture with CFG Law
25th Jul 20227:00 amRNSFEN Announces Joint Venture with CFG Law
12th Jul 202210:50 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSResults of Placing
5th Jul 20222:45 pmRNSProposed Placing to raise approximately £10m
22nd Jun 202211:40 amRNSResult of AGM
16th May 20228:25 amRNSAnnual Report Posting, Notice of AGM & Dividend
4th May 20221:00 pmRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.